PMID- 29298351 OWN - NLM STAT- MEDLINE DCOM- 20180215 LR - 20181113 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 13 IP - 1 DP - 2018 TI - Functional consequences of piceatannol binding to glyceraldehyde-3-phosphate dehydrogenase. PG - e0190656 LID - 10.1371/journal.pone.0190656 [doi] LID - e0190656 AB - Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is one of the key redox-sensitive proteins whose activity is largely affected by oxidative modifications at its highly reactive cysteine residue in the enzyme's active site (Cys149). Prolonged exposure to oxidative stress may cause, inter alia, the formation of intermolecular disulfide bonds leading to accumulation of GAPDH aggregates and ultimately to cell death. Recently these anomalies have been linked with the pathogenesis of Alzheimer's disease. Novel evidences indicate that low molecular compounds may be effective inhibitors potentially preventing the GAPDH translocation to the nucleus, and inhibiting or slowing down its aggregation and oligomerization. Therefore, we decided to establish the ability of naturally occurring compound, piceatannol, to interact with GAPDH and to reveal its effect on functional properties and selected parameters of the dehydrogenase structure. The obtained data revealed that piceatannol binds to GAPDH. The ITC analysis indicated that one molecule of the tetrameric enzyme may bind up to 8 molecules of polyphenol (7.3 +/- 0.9). Potential binding sites of piceatannol to the GAPDH molecule were analyzed using the Ligand Fit algorithm. Conducted analysis detected 11 ligand binding positions. We indicated that piceatannol decreases GAPDH activity. Detailed analysis allowed us to presume that this effect is due to piceatannol ability to assemble a covalent binding with nucleophilic cysteine residue (Cys149) which is directly involved in the catalytic reaction. Consequently, our studies strongly indicate that piceatannol would be an exceptional inhibitor thanks to its ability to break the aforementioned pathologic disulfide linkage, and therefore to inhibit GAPDH aggregation. We demonstrated that by binding with GAPDH piceatannol blocks cysteine residue and counteracts its oxidative modifications, that induce oligomerization and GAPDH aggregation. FAU - Gerszon, Joanna AU - Gerszon J AUID- ORCID: 0000-0001-9754-4108 AD - Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland. AD - Bionanopark Ltd., Lodz, Poland. FAU - Serafin, Eligiusz AU - Serafin E AD - Laboratory of Computer and Analytical Techniques, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland. FAU - Buczkowski, Adam AU - Buczkowski A AD - Unit of Biophysical Chemistry, Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Lodz, Poland. FAU - Michlewska, Sylwia AU - Michlewska S AD - Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland. AD - Laboratory of Microscopic Imaging and Specialized Biological Techniques, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland. FAU - Bielnicki, Jakub Antoni AU - Bielnicki JA AD - Bionanopark Ltd., Lodz, Poland. FAU - Rodacka, Aleksandra AU - Rodacka A AD - Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180103 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Ligands) RN - 0 (Stilbenes) RN - 6KS3LS0D4F (3,3',4,5'-tetrahydroxystilbene) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 1.2.1.- (Glyceraldehyde-3-Phosphate Dehydrogenases) SB - IM MH - Calorimetry MH - Catalytic Domain MH - Circular Dichroism MH - Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry/*metabolism MH - Hydrogen Peroxide/metabolism MH - Ligands MH - Microscopy, Electron, Transmission MH - Models, Molecular MH - Protein Binding MH - Protein Structure, Secondary MH - Stilbenes/*metabolism PMC - PMC5752021 COIS- Competing Interests: The involvement of Bionanopark Ltd. does not alter our adherence to PLOS ONE policies on sharing data and materials. EDAT- 2018/01/04 06:00 MHDA- 2018/02/16 06:00 PMCR- 2018/01/03 CRDT- 2018/01/04 06:00 PHST- 2017/09/20 00:00 [received] PHST- 2017/12/18 00:00 [accepted] PHST- 2018/01/04 06:00 [entrez] PHST- 2018/01/04 06:00 [pubmed] PHST- 2018/02/16 06:00 [medline] PHST- 2018/01/03 00:00 [pmc-release] AID - PONE-D-17-34199 [pii] AID - 10.1371/journal.pone.0190656 [doi] PST - epublish SO - PLoS One. 2018 Jan 3;13(1):e0190656. doi: 10.1371/journal.pone.0190656. eCollection 2018.